Cigarette smoking and the personalization of irinotecan therapy

被引：5
作者：
Benowitz, Neal L. [1 ]
机构：
[1] San Francisco Gen Hosp, Med Ctr, Div Clin Pharmacol & Expt Therapeut, Med Serv,Dept Med, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, Med Ctr, Div Clin Pharmacol & Expt Therapeut, Med Serv,Dept Psychiat, San Francisco, CA 94110 USA
[3] San Francisco Gen Hosp, Med Ctr, Div Clin Pharmacol & Expt Therapeut, Med Serv,Dept Biopharmaceut Sci, San Francisco, CA 94110 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 19期
关键词：
D O I：
10.1200/JCO.2007.10.7359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2646 / 2647
页数：2
相关论文
共 22 条
[1]  
Ando Y, 2000, CANCER RES, V60, P6921
[2]   Cigarette smoking and infection [J].
Arcavi, L ;
Benowitz, NL .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (20) :2206-2216
[3]   Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism [J].
Benowitz, NL ;
Peng, M ;
Jacob, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (05) :468-474
[4]   Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen [J].
Cloughesy, TF ;
Filka, E ;
Kuhn, J ;
Nelson, G ;
Kabbinavar, F ;
Friedman, H ;
Miller, LL ;
Elfring, GL .
CANCER, 2003, 97 (09) :2381-2386
[5]   Successes and failures of the teachable moment - Smoking cessation in cancer patients [J].
Gritz, ER ;
Fingeret, MC ;
Vidrine, DJ ;
Lazev, AB ;
Mehta, NV ;
Reece, GP .
CANCER, 2006, 106 (01) :17-27
[6]   Smoking, the missing drug interaction in clinical trials: Ignoring the obvious [J].
Gritz, ER ;
Dresler, C ;
Sarna, L .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (10) :2287-2293
[7]   CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues [J].
Guichard, S ;
Terret, C ;
Hennebelle, I ;
Lochon, I ;
Chevreau, P ;
Frétigny, E ;
Selves, J ;
Chatelut, E ;
Bugat, R ;
Canal, P .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :364-370
[8]   Effects of smoking on the pharmacokinetics of erlotinib [J].
Hamilton, M ;
Wolf, JL ;
Rusk, J ;
Beard, SE ;
Clark, GM ;
Witt, K ;
Cagnoni, PJ .
CLINICAL CANCER RESEARCH, 2006, 12 (07) :2166-2171
[9]  
Howard LA, 2001, J PHARMACOL EXP THER, V299, P542
[10]   Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan [J].
Innocenti, F ;
Undevia, SD ;
Iyer, L ;
Chen, PX ;
Das, S ;
Kocherginsky, M ;
Karrison, T ;
Janisch, L ;
Ramírez, J ;
Rudin, CM ;
Vokes, EE ;
Ratain, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1382-1388
123